Pearl Health, a healthcare technology company focused on transforming Medicare through artificial intelligence and value-based care, has announced a $110 million capital raise to expand its AI-powered healthcare platform and strengthen partnerships across the Medicare ecosystem. The funding comes as healthcare organizations increasingly adopt AI technologies to improve patient outcomes, streamline operations, and manage rising care costs.
The funding package includes equity investments led by Andreessen Horowitz alongside participation from Viking Global Investors, AlleyCorp, and Ulysses Capital, complemented by a debt facility led by Trinity Capital. Pearl Health plans to use the capital to enhance its AI capabilities, expand risk-management offerings, and accelerate growth across Medicare Advantage and value-based care programs.
AI-Powered Transformation of Medicare Care
Pearl Health's platform leverages artificial intelligence, predictive analytics, and population health management tools to help healthcare providers identify high-risk patients earlier and deliver proactive care interventions. By analyzing large volumes of clinical and operational data, the platform supports physicians in making more informed decisions that improve patient outcomes while reducing unnecessary healthcare expenditures.
The company has emerged as a significant player in the value-based care market, supporting thousands of healthcare providers across the United States. Its AI-driven approach aligns with broader healthcare industry trends where providers increasingly rely on intelligent automation and predictive analytics to improve quality metrics and financial performance.
Growth Backed by Strong Market Performance
Pearl Health reported reaching profitability in 2025, a milestone that distinguishes it within the digital health sector. The company is projected to generate substantial healthcare system savings while expanding its patient base significantly through the end of 2026. Industry observers view this achievement as evidence that AI-enabled value-based care models are moving beyond experimentation toward sustainable commercial adoption.
The organization currently supports hundreds of thousands of Medicare beneficiaries through a nationwide provider network, reflecting the growing demand for technology platforms that help physicians navigate increasingly complex reimbursement and care delivery environments.
Why This Funding Matters for the AI Healthcare Market
The latest investment highlights accelerating investor confidence in healthcare AI platforms that demonstrate measurable clinical and financial outcomes. As healthcare systems face mounting pressure to improve efficiency, reduce costs, and enhance patient experiences, AI-powered care management solutions are becoming strategic priorities for providers, payers, and policymakers.
The funding also reinforces the broader shift toward value-based care models, where healthcare organizations are rewarded for patient outcomes rather than service volume. AI technologies are increasingly viewed as critical enablers of this transition, helping providers identify care gaps, manage chronic conditions, and optimize resource allocation.
Industry Outlook
Healthcare AI adoption continues to accelerate as organizations seek scalable solutions to address workforce shortages, rising Medicare spending, and growing patient populations. Companies capable of combining advanced analytics with proven healthcare outcomes are expected to attract increased investment and market attention in the coming years.
Pearl Health's latest funding round positions the company to capitalize on these trends while expanding its role in the rapidly evolving Medicare and value-based care landscape. As AI becomes increasingly integrated into clinical and operational workflows, the company aims to help providers deliver more personalized, efficient, and cost-effective care for Medicare beneficiaries nationwide.